Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Press/Media

Period	22 Mar 2023

Media coverage

Title	Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
Media name/outlet	ASHPublications.org
Country/Territory	United States
Date	22/03/23
URL	ct.moreover.com/?a=50318949775&p=1gw&v=1&x=XWf06Xv-rJXa9fdXD_Utow
Persons	Samir Parekh